Search

everythinglearnresearchcommunity

for

Search:↓

Some chemotherapy can cause permanent hair loss.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

The study found that horizontal sections of scalp biopsies are better for analyzing hair loss, showing fewer hairs and more fine hairs in balding areas.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

A woman's rare benign eyelid tumor was correctly identified through detailed tissue analysis.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

A man had rare skin tumors with bone formation and cholesterol deposits.

An 8-year-old girl had a rare, benign skin tumor on her forehead.

The research suggests that p63 and TGF-β1 may help determine tumor type and malignancy in hair follicle and sebaceous tumors.

A man had a non-cancerous, fast-growing skin lump on his arm that was removed with surgery.

Trichogerminoma is a rare, benign skin tumor from hair cells, with a small risk of becoming cancerous.

Hair matrix cysts are rare skin nodules with unique features, often needing surgical removal.

The document concludes that understanding how hair follicles naturally die and regenerate is important for insights into organ development and could impact health and disease treatment.

A person had two different benign skin tumors, a trichoadenoma and melanocytic naevi, at the same time but in different places on the face.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Keratoacanthoma comes from hair follicle cells.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

A new classification system for skin cysts was proposed to improve diagnosis.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Some skin tumors from hair follicles and glands can be linked to genetic syndromes and may be benign or malignant.

A rare benign skin nodule was found on the buttock, a unique location for this condition.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.